CT-Agent: Clinical Trial Multi-Agent with Large Language Model-based Reasoning
0
💬
Sign in to get full access
Overview
- Large language models (LLMs) and multi-agent systems have shown impressive capabilities in natural language tasks, but face challenges in clinical trial applications due to limited access to external knowledge.
- Recognizing the potential of advanced clinical trial tools that aggregate and predict based on the latest medical data, the researchers propose an integrated solution to enhance accessibility and utility.
- They introduce Clinical Agent System (CT-Agent), a clinical multi-agent system designed for clinical trial tasks, leveraging GPT-4, multi-agent architectures, LEAST-TO-MOST, and ReAct reasoning technology.
Plain English Explanation
The paper describes a new system called CT-Agent that aims to improve the ability of AI agents to handle clinical trial tasks. Large language models and multi-agent systems have shown promise in understanding and processing natural language, but they have struggled when applied to the specific domain of clinical trials.
The researchers recognized that having access to the latest medical data could help these AI systems perform better in clinical contexts. So they developed an integrated solution that combines several advanced technologies, including the powerful GPT-4 language model, multi-agent architectures that allow different AI components to work together, and reasoning techniques like LEAST-TO-MOST and ReAct.
The result is a CT-Agent system that can autonomously manage the entire clinical trial process, from start to finish. The researchers found that this approach led to significant improvements in efficiency compared to existing methods, based on both computational benchmarks and feedback from experts in the field.
Technical Explanation
The paper introduces CT-Agent, a clinical multi-agent system designed to enhance the performance of large language models (LLMs) and multi-agent systems in clinical trial applications. The researchers recognized that the key limitation of these advanced AI systems in clinical contexts was their lack of access to the latest medical data and knowledge.
To address this, the CT-Agent system integrates several technologies, including:
- GPT-4: A powerful large language model that provides the foundation for natural language understanding and generation.
- Multi-agent architectures: Allow different AI components to work together, each specializing in a particular task or function.
- LEAST-TO-MOST: A reasoning technique that helps the system efficiently navigate the complex clinical trial process.
- ReAct reasoning: Another reasoning approach that allows the system to make decisions and take actions based on the latest medical data and knowledge.
The researchers evaluated the CT-Agent system using both computational benchmarks and expert feedback. Their results show that this integrated approach leads to significant improvements in the efficiency of clinical trial management, compared to existing methods.
Critical Analysis
The paper presents a compelling solution to the challenge of applying advanced AI systems, such as large language models and multi-agent systems, to the specific domain of clinical trials. By leveraging the latest medical data and knowledge, the CT-Agent system is able to overcome the limitations of these AI technologies in clinical contexts.
However, the paper does not discuss in detail the potential limitations or challenges of the CT-Agent system. For example, it's unclear how the system handles the dynamic and evolving nature of medical knowledge, or how it ensures the reliability and accuracy of the data it uses to make decisions.
Additionally, the paper could have explored the ethical implications of using an autonomous AI system to manage clinical trials, such as issues around transparency, accountability, and the potential for biased decision-making. These are important considerations that should be addressed as advanced AI agents are increasingly deployed in high-stakes domains like healthcare.
Conclusion
The CT-Agent system presented in this paper represents a significant step forward in the application of advanced AI technologies to clinical trial management. By integrating large language models, multi-agent architectures, and specialized reasoning techniques, the researchers have developed a solution that can autonomously handle the entire clinical trial process with improved efficiency.
This research has the potential to revolutionize the way clinical trials are conducted, making them more accessible and cost-effective. Furthermore, the CT-Agent system could serve as a foundation for developing even more capable AI agents that can assist healthcare professionals in delivering better patient outcomes.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
💬
0
CT-Agent: Clinical Trial Multi-Agent with Large Language Model-based Reasoning
Ling Yue, Sixue Xing, Jintai Chen, Tianfan Fu
Large Language Models (LLMs) and multi-agent systems have shown impressive capabilities in natural language tasks but face challenges in clinical trial applications, primarily due to limited access to external knowledge. Recognizing the potential of advanced clinical trial tools that aggregate and predict based on the latest medical data, we propose an integrated solution to enhance their accessibility and utility. We introduce Clinical Agent System (ClinicalAgent), a clinical multi-agent system designed for clinical trial tasks, leveraging GPT-4, multi-agent architectures, LEAST-TO-MOST, and ReAct reasoning technology. This integration not only boosts LLM performance in clinical contexts but also introduces novel functionalities. The proposed method achieves competitive predictive performance in clinical trial outcome prediction (0.7908 PR-AUC), obtaining a 0.3326 improvement over the standard prompt Method. Publicly available code can be found at https://anonymous.4open.science/r/ClinicalAgent-6671.
Read more7/23/2024
💬
0
MedAgents: Large Language Models as Collaborators for Zero-shot Medical Reasoning
Xiangru Tang, Anni Zou, Zhuosheng Zhang, Ziming Li, Yilun Zhao, Xingyao Zhang, Arman Cohan, Mark Gerstein
Large language models (LLMs), despite their remarkable progress across various general domains, encounter significant barriers in medicine and healthcare. This field faces unique challenges such as domain-specific terminologies and reasoning over specialized knowledge. To address these issues, we propose MedAgents, a novel multi-disciplinary collaboration framework for the medical domain. MedAgents leverages LLM-based agents in a role-playing setting that participate in a collaborative multi-round discussion, thereby enhancing LLM proficiency and reasoning capabilities. This training-free framework encompasses five critical steps: gathering domain experts, proposing individual analyses, summarising these analyses into a report, iterating over discussions until a consensus is reached, and ultimately making a decision. Our work focuses on the zero-shot setting, which is applicable in real-world scenarios. Experimental results on nine datasets (MedQA, MedMCQA, PubMedQA, and six subtasks from MMLU) establish that our proposed MedAgents framework excels at mining and harnessing the medical expertise within LLMs, as well as extending its reasoning abilities. Our code can be found at https://github.com/gersteinlab/MedAgents.
Read more6/6/2024
🌿
0
Natural Language Programming in Medicine: Administering Evidence Based Clinical Workflows with Autonomous Agents Powered by Generative Large Language Models
Akhil Vaid, Joshua Lampert, Juhee Lee, Ashwin Sawant, Donald Apakama, Ankit Sakhuja, Ali Soroush, Sarah Bick, Ethan Abbott, Hernando Gomez, Michael Hadley, Denise Lee, Isotta Landi, Son Q Duong, Nicole Bussola, Ismail Nabeel, Silke Muehlstedt, Silke Muehlstedt, Robert Freeman, Patricia Kovatch, Brendan Carr, Fei Wang, Benjamin Glicksberg, Edgar Argulian, Stamatios Lerakis, Rohan Khera, David L. Reich, Monica Kraft, Alexander Charney, Girish Nadkarni
Generative Large Language Models (LLMs) hold significant promise in healthcare, demonstrating capabilities such as passing medical licensing exams and providing clinical knowledge. However, their current use as information retrieval tools is limited by challenges like data staleness, resource demands, and occasional generation of incorrect information. This study assessed the potential of LLMs to function as autonomous agents in a simulated tertiary care medical center, using real-world clinical cases across multiple specialties. Both proprietary and open-source LLMs were evaluated, with Retrieval Augmented Generation (RAG) enhancing contextual relevance. Proprietary models, particularly GPT-4, generally outperformed open-source models, showing improved guideline adherence and more accurate responses with RAG. The manual evaluation by expert clinicians was crucial in validating models' outputs, underscoring the importance of human oversight in LLM operation. Further, the study emphasizes Natural Language Programming (NLP) as the appropriate paradigm for modifying model behavior, allowing for precise adjustments through tailored prompts and real-world interactions. This approach highlights the potential of LLMs to significantly enhance and supplement clinical decision-making, while also emphasizing the value of continuous expert involvement and the flexibility of NLP to ensure their reliability and effectiveness in healthcare settings.
Read more8/23/2024
0
ArgMed-Agents: Explainable Clinical Decision Reasoning with LLM Disscusion via Argumentation Schemes
Shengxin Hong, Liang Xiao, Xin Zhang, Jianxia Chen
There are two main barriers to using large language models (LLMs) in clinical reasoning. Firstly, while LLMs exhibit significant promise in Natural Language Processing (NLP) tasks, their performance in complex reasoning and planning falls short of expectations. Secondly, LLMs use uninterpretable methods to make clinical decisions that are fundamentally different from the clinician's cognitive processes. This leads to user distrust. In this paper, we present a multi-agent framework called ArgMed-Agents, which aims to enable LLM-based agents to make explainable clinical decision reasoning through interaction. ArgMed-Agents performs self-argumentation iterations via Argumentation Scheme for Clinical Discussion (a reasoning mechanism for modeling cognitive processes in clinical reasoning), and then constructs the argumentation process as a directed graph representing conflicting relationships. Ultimately, use symbolic solver to identify a series of rational and coherent arguments to support decision. We construct a formal model of ArgMed-Agents and present conjectures for theoretical guarantees. ArgMed-Agents enables LLMs to mimic the process of clinical argumentative reasoning by generating explanations of reasoning in a self-directed manner. The setup experiments show that ArgMed-Agents not only improves accuracy in complex clinical decision reasoning problems compared to other prompt methods, but more importantly, it provides users with decision explanations that increase their confidence.
Read more6/24/2024